首页> 外文OA文献 >In Vitro Analysis of Virus Particle Subpopulations in Candidate Live-Attenuated Influenza Vaccines Distinguishes Effective from Ineffective Vaccines▿
【2h】

In Vitro Analysis of Virus Particle Subpopulations in Candidate Live-Attenuated Influenza Vaccines Distinguishes Effective from Ineffective Vaccines▿

机译:活检弱毒候选疫苗中病毒颗粒亚群的体外分析可有效鉴别无效疫苗▿

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Two effective (vac+) and two ineffective (vac−) candidate live-attenuated influenza vaccines (LAIVs) derived from naturally selected genetically stable variants of A/TK/OR/71-delNS1[1-124] (H7N3) that differed only in the length and kind of amino acid residues at the C terminus of the nonstructural NS1 protein were analyzed for their content of particle subpopulations. These subpopulations included total physical particles (measured as hemagglutinating particles [HAPs]) with their subsumed biologically active particles of infectious virus (plaque-forming particles [PFPs]) and different classes of noninfectious virus, namely, interferon-inducing particles (IFPs), noninfectious cell-killing particles (niCKPs), and defective interfering particles (DIPs). The vac+ variants were distinguished from the vac− variants on the basis of their content of viral subpopulations by (i) the capacity to induce higher quantum yields of interferon (IFN), (ii) the generation of an unusual type of IFN-induction dose-response curve, (iii) the presence of IFPs that induce IFN more efficiently, (iv) reduced sensitivity to IFN action, and (v) elevated rates of PFP replication that resulted in larger plaques and higher PFP and HAP titers. These in vitro analyses provide a benchmark for the screening of candidate LAIVs and their potential as effective vaccines. Vaccine design may be improved by enhancement of attributes that are dominant in the effective (vac+) vaccines.
机译:从A / TK / OR / 71-delNS1 [1-124](H7N3)的自然选择的遗传稳定变异体中衍生出的两种有效(vac +)和两种无效(vac-)候选减毒活疫苗(LAIV)分析了非结构NS1蛋白C末端氨基酸残基的长度和种类,以了解其颗粒亚群的含量。这些亚群包括总物理颗粒(以血凝颗粒[HAPs]衡量)及其传染性病毒的生物活性颗粒(噬斑形成颗粒[PFPs])和不同类别的非传染性病毒,即干扰素诱导颗粒(IFPs),非感染性细胞杀伤颗粒(niCKP)和有缺陷的干扰颗粒(DIP)。根据其病毒亚群的含量,将vac +变体与vac-变体区分开来:(i)诱导更高的干扰素(IFN)量子产率的能力,(ii)产生异常类型的IFN诱导剂量-响应曲线,(iii)存在更有效诱导IFN的IFP,(iv)对IFN作用的敏感性降低,和(v)提高PFP复制速率,导致噬菌斑更大,PFP和HAP滴度更高。这些体外分析为筛选候选LAIV及其作为有效疫苗的潜力提供了基准。可以通过增强有效(vac +)疫苗中占主导地位的属性来改善疫苗设计。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号